Erythropoiesis-stimulating agents for anemic patients with cancer.
about
Differential platelet levels affect response to taxane-based therapy in ovarian cancer.Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers.Enhanced eryptosis contributes to anemia in lung cancer patientsImage-based 3D modeling study of the influence of vessel density and blood hemoglobin concentration on tumor oxygenation and response to irradiation.
P2860
Erythropoiesis-stimulating agents for anemic patients with cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Erythropoiesis-stimulating agents for anemic patients with cancer.
@en
Erythropoiesis-stimulating agents for anemic patients with cancer.
@nl
type
label
Erythropoiesis-stimulating agents for anemic patients with cancer.
@en
Erythropoiesis-stimulating agents for anemic patients with cancer.
@nl
prefLabel
Erythropoiesis-stimulating agents for anemic patients with cancer.
@en
Erythropoiesis-stimulating agents for anemic patients with cancer.
@nl
P2860
P356
P1476
Erythropoiesis-stimulating agents for anemic patients with cancer.
@en
P2093
Semira Sheikh
Tim J Littlewood
P2860
P304
P356
10.1586/EHM.10.64
P577
2010-12-01T00:00:00Z